Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
226M
-
Number of holders
-
989
-
Total 13F shares, excl. options
-
223M
-
Shares change
-
-1.81M
-
Total reported value, excl. options
-
$53.5B
-
Value change
-
-$531M
-
Put/Call ratio
-
1.21
-
Number of buys
-
446
-
Number of sells
-
-480
-
Price
-
$240.10
Significant Holders of Elevance Health, Inc. - Common Stock (ELV) as of Q3 2019
1,154 filings reported holding ELV - Elevance Health, Inc. - Common Stock as of Q3 2019.
Elevance Health, Inc. - Common Stock (ELV) has 989 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 223M shares
of 226M outstanding shares and own 98.6% of the company stock.
Largest 10 shareholders include BlackRock Inc. (22.8M shares), VANGUARD GROUP INC (19.5M shares), PRICE T ROWE ASSOCIATES INC /MD/ (11.9M shares), STATE STREET CORP (11.1M shares), WELLINGTON MANAGEMENT GROUP LLP (8.5M shares), FMR LLC (7.86M shares), Invesco Ltd. (5.7M shares), Capital International Investors (5.68M shares), BAILLIE GIFFORD & CO (4.28M shares), and TCI FUND MANAGEMENT LTD (4.08M shares).
This table shows the top 989 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.